Yousef Zakharia

36PUBLICATIONS
244CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 21, 2026
Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma.

|Jul 01, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

|May 20, 2026
Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

|Feb 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer.

Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos

|Dec 05, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.

Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto

|Oct 28, 2025
Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer.

Prithvi Raj, Jialiang Liu, Chengsong Zhu

Pageof 6

Frequent Collaborators

4 joint publications

Cornelia M Ulrich

4 joint publications

Aliasger K Salem

4 joint publications

Caroline E Wheeler

4 joint publications

Sheetal Hardikar